Teva Pharmaceutical Industries Ltd
F:TEV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Teva Pharmaceutical Industries Ltd
F:TEV
|
IL |
|
C
|
Columbia Sportswear Co
XMUN:CUW
|
US |
Intrinsic Value
The intrinsic value of 
Teva Pharmaceutical Industries Ltd (TEV) under the Base Case is 22.1 EUR per share.
Compared with the current market price of 30.7 EUR, the stock appears
Overvalued by 28% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Teva Pharmaceutical Industries Does
Teva Pharmaceutical Industries is a global drug company best known for making generic medicines, which are lower-cost versions of branded drugs after patent protection ends. It also sells a smaller portfolio of branded specialty medicines, with a focus on treatments for the nervous system, breathing problems, and other chronic conditions. Its products are sold to pharmacies, hospitals, doctors, governments, and health systems around the world.
- Headquarters
- Israel IL
- Employees
- 31 173
- IPO date
- Jan 1, 1951
Teva Pharmaceutical Industries has no economic moat
Rival manufacturers can offer alternatives to many of Teva’s medicines, giving large drug buyers room to demand lower prices or choose another supplier. Patents protect some branded treatments, but do not keep competitors away from enough of Teva’s business to provide lasting protection overall.
Read the full moat analysis
Revenue & Expenses Breakdown
Teva Pharmaceutical Industries Ltd
Earnings Waterfall
Teva Pharmaceutical Industries Ltd
The intrinsic value for Teva Pharmaceutical Industries Ltd (TEV) under the Base Case is 22.1 EUR.
Compared with the current market price of 30.7 EUR, the stock appears Overvalued by 28% .